GoHealth (GOCO) Common Equity (2019 - 2026)

GoHealth has disclosed Common Equity across 8 years of filings, most recently posting -$126.7 million for Q1 2026.

• Common Equity for Q1 2026 came in at -$126.7 million, down 131.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$126.7 million (down 131.91% YoY), and the FY2025 annual result was $37.9 million, down 90.66% from the prior year.
• Common Equity came in at -$126.7 million for Q1 2026 at GoHealth, down from $37.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $860.0 million in Q1 2022 to a low of -$126.7 million in Q1 2026.
• The 5-year median for Common Equity is $404.6 million (2023), against an average of $393.5 million.
• Across the five-year window, Common Equity gained 2.97% in 2025 and sank 131.91% in 2026, its largest moves.
• GoHealth's Common Equity stood at $542.4 million in 2022, then fell by 25.21% to $405.7 million in 2023, then retreated by 0.05% to $405.4 million in 2024, then sank by 90.66% to $37.9 million in 2025, then slumped by 434.54% to -$126.7 million in 2026.
• The last three Common Equity figures came in at -$126.7 million (Q1 2026), $37.9 million (Q4 2025), and -$6.9 million (Q3 2025), per Business Quant data.